Group One Trading’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,000
Closed -$10.9K 8370
2026
Q1
$10.9K Buy
15,000
+14,060
+1,496% +$64K ﹤0.01% 6328
2025
Q4
$5.25K Buy
940
+810
+623% +$9.01K ﹤0.01% 7161
2025
Q3
$958 Sell
130
-80
-38% -$680 ﹤0.01% 8064
2025
Q2
$1.6K Sell
210
-1,430
-87% -$22.3K ﹤0.01% 7469
2025
Q1
$31.3K Sell
1,640
-5,145
-76% -$162K ﹤0.01% 5517
2024
Q4
$246K Buy
6,785
+4,935
+267% +$137K ﹤0.01% 3778
2024
Q3
$53.3K Sell
1,850
-730
-28% -$16.2K ﹤0.01% 4622
2024
Q2
$66K Sell
2,580
-80
-3% -$3.64K ﹤0.01% 4296
2024
Q1
$201K Buy
2,660
+775
+41% +$61.4K ﹤0.01% 3558
2023
Q4
$194K Sell
1,885
-9,590
-84% -$861K ﹤0.01% 3890
2023
Q3
$1.12M Buy
11,475
+9,865
+613% +$920K ﹤0.01% 2150
2023
Q2
$189K Buy
1,610
+1,570
+3,925% +$199K ﹤0.01% 3995
2023
Q1
$3.35K Sell
40
-75
-65% -$6.55K ﹤0.01% 6457
2022
Q4
$9.78K Buy
115
+40
+53% +$3.05K ﹤0.01% 6040
2022
Q3
$2K Buy
+75
New +$2.07K ﹤0.01% 7195

Other funds holding RVPH

Group One Trading's RVPH Position: Q2 2026 in Review

Group One Trading sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 3,109 shares — an estimated $2.27K sold.

Group One Trading first reported a position in RVPH in Q3 2023 and held it in 5 quarters. The position peaked at $631K in Q3 2023. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

  • Group One Trading reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 3,109 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $2.27K.
  • Group One Trading first reported a position in REVIVA PHARMA HLDGS INC in Q3 2023 and held it in 5 quarters.
  • Group One Trading's REVIVA PHARMA HLDGS INC position peaked at $631K in Q3 2023.
  • 5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.